Acorah Software Products - Accounts Production 19.4.351 false true 31 October 2024 23 October 2023 false 1 November 2024 31 October 2025 31 October 2025 15244860 Mr Mohammed-Akram Alainachi Mr Sohail Yaqub iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 15244860 2024-10-31 15244860 2025-10-31 15244860 2024-11-01 2025-10-31 15244860 frs-core:CurrentFinancialInstruments 2025-10-31 15244860 frs-core:ShareCapital 2025-10-31 15244860 frs-core:RetainedEarningsAccumulatedLosses 2025-10-31 15244860 frs-bus:PrivateLimitedCompanyLtd 2024-11-01 2025-10-31 15244860 frs-bus:FilletedAccounts 2024-11-01 2025-10-31 15244860 frs-bus:SmallEntities 2024-11-01 2025-10-31 15244860 frs-bus:AuditExempt-NoAccountantsReport 2024-11-01 2025-10-31 15244860 frs-bus:SmallCompaniesRegimeForAccounts 2024-11-01 2025-10-31 15244860 frs-bus:Director1 2024-11-01 2025-10-31 15244860 frs-bus:Director2 2024-11-01 2025-10-31 15244860 frs-countries:EnglandWales 2024-11-01 2025-10-31 15244860 2023-10-22 15244860 2024-10-31 15244860 2023-10-23 2024-10-31 15244860 frs-core:CurrentFinancialInstruments 2024-10-31 15244860 frs-core:ShareCapital 2024-10-31 15244860 frs-core:RetainedEarningsAccumulatedLosses 2024-10-31
Registered number: 15244860
Vital Meds Limited
Unaudited Financial Statements
For The Year Ended 31 October 2025
Contents
Page
Balance Sheet 1
Notes to the Financial Statements 2
Page 1
Balance Sheet
Registered number: 15244860
31 October 2025 31 October 2024
Notes £ £ £ £
CURRENT ASSETS
Debtors 4 1 1
1 1
Creditors: Amounts Falling Due Within One Year 5 (28,523 ) -
NET CURRENT ASSETS (LIABILITIES) (28,522 ) 1
TOTAL ASSETS LESS CURRENT LIABILITIES (28,522 ) 1
NET (LIABILITIES)/ASSETS (28,522 ) 1
CAPITAL AND RESERVES
Called up share capital 6 1 1
Profit and Loss Account (28,523 ) -
SHAREHOLDERS' FUNDS (28,522) 1
For the year ending 31 October 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Mr Sohail Yaqub
Director
03/11/2025
The notes on page 2 form part of these financial statements.
Page 1
Page 2
Notes to the Financial Statements
1. General Information
Vital Meds Limited is a private company, limited by shares, incorporated in England & Wales, registered number 15244860 . The registered office is VITAL MEDS LIMITED, 1st Floor, Portfolio Place 498 Broadway Chadderton, Oldham, OL9 9PY.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
3. Average Number of Employees
0Average number of employees, including directors, during the year was: NIL (2024: NIL)
- -
4. Debtors
31 October 2025 31 October 2024
£ £
Due within one year
Other debtors 1 1
5. Creditors: Amounts Falling Due Within One Year
31 October 2025 31 October 2024
£ £
Other creditors 28,523 -
6. Share Capital
31 October 2025 31 October 2024
£ £
Called Up Share Capital not Paid 1 1
Amount of Allotted, Called Up Share Capital 1 1
Page 2